CH437301A - Process for the preparation of benzo (a) quinolizine derivatives - Google Patents

Process for the preparation of benzo (a) quinolizine derivatives

Info

Publication number
CH437301A
CH437301A CH26664A CH26664A CH437301A CH 437301 A CH437301 A CH 437301A CH 26664 A CH26664 A CH 26664A CH 26664 A CH26664 A CH 26664A CH 437301 A CH437301 A CH 437301A
Authority
CH
Switzerland
Prior art keywords
benzo
formula
quinolizine
ethyl
hexahydro
Prior art date
Application number
CH26664A
Other languages
German (de)
Inventor
Tacon Openshaw Harry
Whittaker Norman
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB39935/59A external-priority patent/GB999092A/en
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of CH437301A publication Critical patent/CH437301A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D455/00Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/03Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/04Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
    • C07D455/06Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine containing benzo [a] quinolizine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Description

  

  Verfahren zur Herstellung von Benzo(a)chinolizinderivaten    Das Hauptpatent betrifft ein Verfahren zur Herstel  lung von Benzo(a)chinolizinderivaten der Formel  
EMI0001.0000     
    oder von deren Spiegelbildern, in welcher Formel R1 eine  Alkylgruppe mit 1 bis 4 Kohlenstaffatomen, R2 eine  Hydroxyl- oder eine niedere Alkoxygruppe bedeuten und  R3 und R4 Methyl- oder Athylgruppen oder R3 und R4  zusammen eine Alkylengruppe sind, wobei man eine ent  sprechende Verbindung der Formel  
EMI0001.0001     
    katalytisch     hydriert.     



  In den     Ausführungsbeispielen    des     Hauptpatentes     wird die Verwendung von Platin als Katalysator be  schrieben.  



  Die vorliegende Erfindung betrifft nun eine Verbes  serung dieses     Verfahrens,    welche dadurch gekennzeich  net ist, dass man als Katalysator Palladium verwendet.  Mit     Hilfe    dieses verbesserten     Verfahrens        können    höhere  Ausbeuten erzielt werden.    <I>Beispiel 1</I>  3 g racemisches     3-Äthyl-1,2,3,4,6,7-hexahydro-9,10-          dimethoxy-2-methaxycarbanylmethylen-11bH-benzo.(a     chinolizin (II) werden in 30 ml Methanol gelöst, die ein       wenig    mehr als 1 Äquivalent Chlorwasserstoff enthalten.  4 g palladisierte Holzkohle (10 0/o Palladium) werden  dann zugefügt und die Mischung unter Wasserstoff ge  schüttelt.

   Nach 8 Stunden ist die     Absorption    von 293     ml     Wasserstoff bei 22 C und 759 mm. Hg beendet. Die Lö  sung wird vom Katalysator abfiltriert, im Vakuum ein  gedampft und der     zurückbleibende        gummiartige    Stoff in  kaltem Wasser, das mit Kaliumhydroxyd basisch ge  macht wurde, gelöst und mit Äther     extrahiert.    Der     äthe-          rische    Extrakt wird mit Wasser gewaschen, über wasser  freiem Natriumsulfat     getrocknet    und eingedampft.

   Der  erhaltene     gummiartige    Stoff wird     durch    Lösen in heissem  Petroläther (Siedebereich 60-80  C) und Eindampfen  der Petrolätherlösung im Vakuum von ,Ätherspuren be  freit.     Schliesslich    wird der     gummiartige    Stoff aus einer  kleinen Menge Petroläther (Siedebereich 60-80  C) kri  stallisiert und liefert 2,23 g racemisches  6,7-hexahydro-9,10-dimethoxy-2-methoxy-carbonyl-11b  H-benzo(a)chinolizin (I) vom Schmelzpunkt 79-81 C.

      <I>Beispiel 2</I>  6,18 g     (+)-3-Äthyl-1,2,3,4,6,7-hexahydro-9,10-di-          methoxy    - 2 - äthoxycarbonylmethylen -11bH - benzo(a)  chinolizin, [a&alpha;D21 = +44  (c = 1 in Äthanol), werden  in 50     ml        Äthanol        suspendiert    und durch Zugabe von  12,1 ml 26%igem äthanolischem Chlorwasserstoff ge  löst, worauf     eine    schwach     saure    Lösung erhalten wird.

    Nach Zugabe von 6 g Katalysator (5%iges Palladium auf  Tonerde) wird die Lösung unter Wasserstoff bei 1 atm  geschüttelt, bis die     Absorption    beendet ist, was     ungefähr     45 Minuten in     Anspruch        reimt.    Das Produkt wird     ge-          mäss    dem in Beispiel 1 beschriebenen Vorgehen abge  trennt und liefert 4,2 g (-)-3-Äthyl-1,2,3,4,6,7-hexa       hydro-9,10-dimethoxy-2-äthoxycarbonylmethyl-11bH-          benzo(a)chinolizin    vom     Schmelzpunkt    88-89  C,     [a]Dzo     -39  (c = 1.

   in     Äthanol).         <I>Beispiel 3</I>  8,00 g     (+)-3-Äthyl-1,2,3,4,6,7-hexahydro-9,10-di-          methoxy    - 2 -äthoxycarbonylmethylen -11bH - benzo(a)  chinolizin, [a&alpha;D21 = +44  (c = 1 in Äthanol), werden in  80 ml     Äthanol    gelöst, die ein wenig mehr als ein Äqui  valent     Chlorwasserstoff    enthalten.

   Dann setzt man 1,2 g  Palladiumoxydkatalysator zu und schüttelt die Lösung  unter Wasserstoff bei 1 atm, bis die Absorption beendet  ist, was     ungefähr    50 Stunden in     Anspruch        nimmt.        Das     Produkt wird gemäss dem im Beispiel 1 beschriebenen  Vorgehen abgetrennt, und man erhält 6,02 g (-)-3-Äth       yl-1,2,3,4,6,7-hexahydro-9,10-dimethoxy-2-äthoxycarb-          onylmethyl-11bH-benzo(a)chinolizin    vom Schmelzpunkt  89-90  C, [a&alpha;D25 = -4.0  (c = 1 in Äthanol).



  Process for the preparation of benzo (a) quinolizine derivatives The main patent relates to a process for the preparation of benzo (a) quinolizine derivatives of the formula
EMI0001.0000
    or their mirror images, in which formula R1 is an alkyl group with 1 to 4 carbon atoms, R2 is a hydroxyl or lower alkoxy group and R3 and R4 are methyl or ethyl groups or R3 and R4 together are an alkylene group, where one is a corresponding compound of formula
EMI0001.0001
    catalytically hydrogenated.



  In the exemplary embodiments of the main patent, the use of platinum as a catalyst is described.



  The present invention now relates to an improvement in this process, which is characterized in that palladium is used as the catalyst. With the help of this improved process, higher yields can be achieved. <I> Example 1 </I> 3 g of racemic 3-ethyl-1,2,3,4,6,7-hexahydro-9,10-dimethoxy-2-methaxycarbanylmethylene-11bH-benzo. (A quinolizine (II) are dissolved in 30 ml of methanol containing a little more than 1 equivalent of hydrogen chloride, 4 g of palladiumized charcoal (10 0 / o palladium) are then added and the mixture is shaken under hydrogen.

   After 8 hours the absorption of 293 ml of hydrogen is at 22 C and 759 mm. Hg finished. The solution is filtered off from the catalyst, evaporated in vacuo and the remaining gummy substance is dissolved in cold water that has been made basic with potassium hydroxide and extracted with ether. The ethereal extract is washed with water, dried over anhydrous sodium sulfate and evaporated.

   The rubbery material obtained is freed from traces of ether by dissolving it in hot petroleum ether (boiling range 60-80 C) and evaporating the petroleum ether solution in vacuo. Finally, the gummy material is crystallized from a small amount of petroleum ether (boiling range 60-80 C) and gives 2.23 g of racemic 6,7-hexahydro-9,10-dimethoxy-2-methoxycarbonyl-11b H-benzo (a ) quinolizine (I) melting point 79-81 C.

      <I> Example 2 </I> 6.18 g (+) - 3-ethyl-1,2,3,4,6,7-hexahydro-9,10-dimethoxy-2-ethoxycarbonylmethylene -11bH-benzo (a) Quinolizine, [a? D21 = +44 (c = 1 in ethanol), are suspended in 50 ml of ethanol and dissolved by adding 12.1 ml of 26% ethanolic hydrogen chloride, whereupon a weakly acidic solution is obtained.

    After adding 6 g of catalyst (5% palladium on alumina), the solution is shaken under hydrogen at 1 atm until the absorption is complete, which rhymes with about 45 minutes. The product is separated off according to the procedure described in Example 1 and gives 4.2 g of (-) - 3-ethyl-1,2,3,4,6,7-hexahydro-9,10-dimethoxy-2 -ethoxycarbonylmethyl-11bH-benzo (a) quinolizine of melting point 88-89 C, [a] Dzo -39 (c = 1.

   in ethanol). <I> Example 3 </I> 8.00 g (+) - 3-ethyl-1,2,3,4,6,7-hexahydro-9,10-dimethoxy-2-ethoxycarbonylmethylene -11bH-benzo (a) Quinolizine, [aαD21 = +44 (c = 1 in ethanol), are dissolved in 80 ml of ethanol containing a little more than one equivalent of hydrogen chloride.

   1.2 g of palladium oxide catalyst are then added and the solution is shaken under hydrogen at 1 atm until absorption has ceased, which takes about 50 hours. The product is separated off according to the procedure described in Example 1, and 6.02 g of (-) - 3-ethyl-1,2,3,4,6,7-hexahydro-9,10-dimethoxy-2- are obtained ethoxycarbonylmethyl-11bH-benzo (a) quinolizine, melting point 89-90 C, [aαD25 = -4.0 (c = 1 in ethanol).

 

Claims (1)

PATENTANSPRUCH Verfahren zur Herstellung von 11bH-Benzo(a)chinol- izinderivaten der Formel EMI0002.0012 oder von deren Spiegelbildern, in welcher Formel R1 eine Alkylgruppe mit 1 bis 4 Kohlenstoffatomen, R= eine Hydroxyl- oder eine niedere Alkoxygruppe bedeuten und R3 und R4 Methyl- oder Äthylgruppen oder R3 und R4 zusammen eine Alkylengruppe sind, wobei man eine ent sprechende Verbindung der Formel EMI0002.0014 katalytisch hydriert, dadurch gekennzeichnet, dass man als Hydrierungskatalysator Palladium verwendet. UNTERANSPRÜCHE 1. PATENT CLAIM Process for the preparation of 11bH-Benzo (a) quinolizine derivatives of the formula EMI0002.0012 or their mirror images, in which formula R1 is an alkyl group with 1 to 4 carbon atoms, R = a hydroxyl or a lower alkoxy group and R3 and R4 are methyl or ethyl groups or R3 and R4 together are an alkylene group, one being a corresponding compound the formula EMI0002.0014 catalytically hydrogenated, characterized in that the hydrogenation catalyst used is palladium. SUBCLAIMS 1. Verfahren nach Patentansrpuch, dadurch gekenn zeichnet, dass man die katalytische Hydrierung unter sauren Bedingungen durchführt. 2. Verfahren nach Patentanspruch, dadurch gekenn zeichnet, dass man das (+)-Enantiomere der Verbindung der Formel (II) verwendet und in das (-)-Enantiomere der Verbindung der Formel (I) überführt. 3. Process according to patent claim, characterized in that the catalytic hydrogenation is carried out under acidic conditions. 2. The method according to claim, characterized in that the (+) - enantiomer of the compound of the formula (II) is used and converted into the (-) - enantiomer of the compound of the formula (I). 3. Verfahren nach Patentanspruch, dadurch gekenn zeichnet, dass man ein 2-Alkoxycarbonylmethyl-3-äthyl- 1,2,3,4,6,7-hexahydro 9,10-dimethoxy-11bH-benzo(a) chinolizin durch Hydrierung von einem 2-Alkoxycarbon ylmethylen-3-äthyl-1,2,3,4,6,7-hexahydro-9,10-dimeth- oxy-11bH-benzo(a)chinolizin herstellt. Process according to claim, characterized in that a 2-alkoxycarbonylmethyl-3-ethyl-1,2,3,4,6,7-hexahydro 9,10-dimethoxy-11bH-benzo (a) quinolizine is produced by hydrogenation of a 2 -Alkoxycarbonylmethylene-3-ethyl-1,2,3,4,6,7-hexahydro-9,10-dimethoxy-11bH-benzo (a) quinolizine.
CH26664A 1959-11-24 1964-01-10 Process for the preparation of benzo (a) quinolizine derivatives CH437301A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB39935/59A GB999092A (en) 1959-11-24 1959-11-24 Method for making benzo(a)-quinolizine derivatives
CH1308560A CH408016A (en) 1959-11-24 1960-11-22 Process for the preparation of benzo (a) -quinolizines
GB247663 1963-01-21

Publications (1)

Publication Number Publication Date
CH437301A true CH437301A (en) 1967-06-15

Family

ID=27176948

Family Applications (1)

Application Number Title Priority Date Filing Date
CH26664A CH437301A (en) 1959-11-24 1964-01-10 Process for the preparation of benzo (a) quinolizine derivatives

Country Status (1)

Country Link
CH (1) CH437301A (en)

Similar Documents

Publication Publication Date Title
CH437301A (en) Process for the preparation of benzo (a) quinolizine derivatives
DE657526C (en) Process for the preparation of esters of 9-Oxyfluorencarbonsaeure- (9)
AT226707B (en) Process for the preparation of new 11b-benzo- (a) -quinolizine derivatives
DE2013256C (en)
CH345016A (en) Process for the preparation of p-oxy-phenylamides
CH414675A (en) Process for the preparation of N-substituted derivatives of 2-amino-1- (2,5-dimethoxyphenyl) -propan-1-ol
DE881663C (en) Process for the preparation of 1- (p-oxyphenyl) -2- (ª ‡ -methyl-ª † -phenyl-propylamino) -propanes
AT226231B (en) Process for the preparation of the stereoisomeric forms of the new, racemic 2-phenyl-2-piperidyl- (2) -ethanol
AT257571B (en) Process for the preparation of the new N-benzyl-α, α-dimethyl-β- (p-fluorophenyl) ethylamine and its salts
DE503924C (en) Process for hydrogenating thebaine
AT324314B (en) PROCESS FOR THE PREPARATION OF NEW 4- (M-BENZOYLPHENYL) -BUTANE (OR -BUTEN-2) ACIDS
AT223203B (en) Process for the preparation of the new optical isomers of 5- (3&#39;-dimethylamino-2&#39;-methylpropyl) -iminodibenzyl
AT200570B (en) Process for the conversion of D-erythro- or L-threo-1- (p-nitrophenyl) -2-amino-1,3-propanediol into D, L-threo-1- (p-nitrophenyl) -2-amino- 1,3-propanediol
AT213883B (en) Process for the preparation of new 3-phenyl-3-pyrrolidinol compounds
AT243268B (en) Process for the preparation of new benzoquinolizine derivatives
AT235280B (en) Process for the production of new indole derivatives
AT233745B (en) Process for the production of reserpic acid esters and their salts
AT219037B (en) Process for the production of new, basic indole derivatives
AT203004B (en) Process for the preparation of new esters of piperidyl- (2) -phenylcarbinol and their salts
DE889156C (en) Process for the production of xanthopterins
CH325296A (en) Process for the preparation of esters of 6-alkoxydropines
AT92388B (en) Process for the preparation of aralkyl esters of benzylamine carboxylic acids.
AT221087B (en) Process for the production of new, basic indole derivatives
AT326655B (en) PROCESS FOR THE PREPARATION OF THE NEW 5- OR 7-FORMYLXANTHONE-2-CARBONIC ACID AND ITS ESTER AMIDES AND SALT
AT238180B (en) Process for the preparation of new pyrrolidine compounds